Explore more publications!

U.S. Senate Approves National Defense Authorization Act

(MENAFN) Lawmakers in the US Senate voted 77–20 on Wednesday to authorize a sweeping $901 billion defense package that will dictate Pentagon spending and strategic priorities through 2026.

The massive legislation, which the House had already approved earlier this month, now awaits President Donald Trump's signature to become law.

Spanning 3,086 pages, the National Defense Authorization Act contains $800 million earmarked for Ukraine through the Ukraine Security Assistance Initiative—distributed as $400 million annually over the next two fiscal years. The measure also eliminates Caesar sanctions previously imposed on Syria during Bashar al-Assad's regime.

Israel will receive $600 million under the bill's provisions, with funding directed toward collaborative missile defense programs including the Iron Dome system.

The legislation addresses strategic competition with China while bolstering Indo-Pacific operations. Taiwan will benefit from $1 billion allocated through the Taiwan Security Cooperation Initiative.

Additional provisions empower the US Department of Defense to invoice NATO member states for costs associated with American military deployments across Eastern Europe. The bill mandates that the US European Command (EUCOM) commander deliver yearly evaluations comparing US-NATO military capabilities against Russia's forces.

Pentagon officials must also analyze national security implications before reducing American troop presence in Europe below 76,000 personnel.

MENAFN18122025000045017169ID1110496609


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions